{"filings":[{"id":91712,"accession_number":"0001213900-26-052833","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","5.07","7.01","9.01"],"status":"ready","headline":"Herbalife Q1 net sales $1.3B (+7.8% YoY); raises FY2026 constant-currency guidance midpoints","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $1.3B (+7.8% YoY); adjusted EBITDA $175.7M above guidance; diluted EPS $0.57, adjusted $0.64.","FY2026 guidance raised: constant-currency net sales and adjusted EBITDA midpoints increased; capex reaffirmed.","Completed $1.45B senior secured debt refinancing on April 29, reducing net leverage to 2.1x.","Acquired substantially all assets of Bioniq's personalized nutrition business on April 30.","Annual meeting: all 11 director nominees elected; say-on-pay and auditor ratification approved."],"consensus_eps_estimate":null,"consensus_eps_actual":0.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":1317200000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91711,"accession_number":"0001213900-26-051010","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["1.01","2.03","2.04","8.01","9.01"],"status":"ready","headline":"Herbalife completes $1.45B refinancing, issues $800M 7.75% notes due 2033, redeems 12.25% notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $800M aggregate principal of 7.750% Senior Secured Notes due 2033 (the '2033 Secured Notes').","Amended 2024 credit facility to $225M Term Loan A and $425M revolving credit facility, both due April 2031.","Used net proceeds and cash to repay $365M term loan B and redeem $800M of 12.250% notes due 2029 at 106.125% of principal.","Expects approximately $45 million in annual cash interest savings from the refinancing.","Approximately $200 million was outstanding under the revolving credit facility as of April 29, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91710,"accession_number":"0001213900-26-044204","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Herbalife prices $800M of 7.750% senior secured notes due 2033; proceeds to refinance higher-cost debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$800M aggregate principal at 7.750% fixed, due 2033; priced at 100% of par.","Interest payable semi-annually on May 1 and Nov 1, starting Nov 1, 2026.","Net proceeds to repay existing debt including 12.250% Senior Secured Notes due 2029.","Offering expected to close April 29, 2026, subject to customary conditions.","Notes not registered; offered under Rule 144A and Regulation S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91709,"accession_number":"0001213900-26-043269","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-04-14T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Herbalife Q1 preliminary net sales growth 7.5-8.0% YoY above guidance; announces $800M notes offering to refinance debt","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Preliminary Q1 net sales growth 7.5-8.0% YoY (5.0-5.5% constant currency), beating high end of guidance; Adj. EBITDA at or above guidance.","Record quarterly net sales in India drove Asia Pacific outperformance; North America and China declined YoY.","Refinancing plan targets $1,450M secured debt ($425M revolver, $225M Term Loan A, $800M other secured notes).","Company proposes $800M senior secured notes due 2033; net proceeds to repay existing debt including 12.250% notes due 2029.","Conditional redemption of existing $800M 2029 notes at 106.125% of par plus accrued interest, contingent on completion of new financing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101969,"accession_number":"0001213900-26-017966","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q4 net sales +6.3% to $1.3B, adj EBITDA $156.1M; Ronaldo invests $7.5M in Pro2col","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $1.3B, +6.3% YoY; constant currency +5.5%; both exceed guidance.","Q4 adj EBITDA $156.1M ($167.7M constant currency); diluted EPS $0.81, adj EPS $0.45.","FY net sales $5.0B (+0.9% YoY), adj EBITDA $657.6M; credit agreement EBITDA $742.0M, leverage 2.8x.","Cristiano Ronaldo invested $7.5M for 10% equity stake in Herbalife's Pro2col Software technology unit."],"consensus_eps_estimate":null,"consensus_eps_actual":2.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":5037500000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118304,"accession_number":"0001213900-25-106671","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q3 net sales $1.3B (+2.7% YoY), adj. EBITDA $163M beats guidance; tightens FY25 ranges","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.3B, above guidance midpoint; up 2.7% YoY (3.2% constant currency).","North America returned to growth with +1.0% YoY, first quarterly gain since Q2 '21.","Adjusted EBITDA $163.0M exceeds guidance; Adjusted EPS $0.50; Net income $43.2M.","Repaid $147.3M of 2025 Notes; leverage ratio reduced to 2.8x.","Full-year guidance tightened: net sales and adj. EBITDA ranges narrowed; Q4 guidance provided."],"consensus_eps_estimate":null,"consensus_eps_actual":1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":3754500000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134751,"accession_number":"0001213900-25-072568","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q2 net sales $1.3B near guidance mid; adjusted EBITDA $173.6M beats; raises 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $1.3B down 1.7% YoY (flat constant currency); net income $49.3M, diluted EPS $0.48.","Adjusted EBITDA $173.6M exceeded guidance; Credit Agreement EBITDA $192.4M; leverage ratio 3.0x.","Adjusted net income $60.5M; adjusted diluted EPS $0.59.","Raised full-year net sales and adjusted EBITDA guidance; launched MultiBurn supplement in July.","Unveiled beta version of Pro2col digital platform and healthy lifespan supplement at July event."],"consensus_eps_estimate":null,"consensus_eps_actual":0.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":2480800000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151657,"accession_number":"0001213900-25-054756","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Herbalife redeems $50M of 7.875% Senior Notes due 2025 at par on June 30","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Redeeming $50 million aggregate principal of 7.875% Senior Notes due 2025 at par.","Redemption date is June 30, 2025; price $1,000 per $1K principal plus accrued interest.","Issuers: Herbalife Ltd. and wholly-owned subsidiary HLF Financing, Inc.","Reduction in outstanding debt lowers future interest expense."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151656,"accession_number":"0001213900-25-037675","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q1 net sales $1.2B (down 3.4% YoY), adjusted EBITDA $164.9M beats guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.2B at midpoint of guidance; down 3.4% YoY but up 1.4% on constant-currency basis.","Net income $50.4M; adjusted net income $59.9M; diluted EPS $0.49, adjusted diluted EPS $0.59.","Adjusted EBITDA $164.9M exceeds guidance; margin up 260 bps vs Q1 '24; leverage ratio reduced to 3.0x.","Full-year 2025 guidance revised: net sales range narrowed, adjusted EBITDA raised, capex reduced.","Completed acquisitions of Pro2col Health and Pruvit Ventures; formed HBL Link Bioscience with 51% ownership."],"consensus_eps_estimate":null,"consensus_eps_actual":0.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":1221700000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151655,"accession_number":"0001213900-25-035657","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Herbalife shareholders elect 11 directors, approve say-on-pay and auditor ratification at 2025 AGM","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 11 board nominees elected with majority votes; Michael O. Johnson received 67.1M for, 1.5M against.","Advisory say-on-pay approved narrowly: 35.3M for, 33.2M against, 323,675 abstentions.","Ratification of PricewaterhouseCoopers as auditor for FY2025 passed with 80.4M for, 2.4M against.","Broker non-votes of 14.2M shares were recorded on director elections and say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170504,"accession_number":"0001213900-25-015314","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q4 Adj EBITDA $150M beats guidance; Stephan Gratziani appointed CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Q4 net sales $1.2B, down 0.6% YoY but up 2.7% constant currency; at high end of guidance.","Q4 adjusted EBITDA $150.0M, exceeding guidance; margin up 340 bps vs Q4'23.","Full-year adjusted EBITDA $634.8M, above guidance; leverage ratio reduced to 3.2x.","Stephan Gratziani appointed CEO effective May 1, 2025; Michael Johnson becomes Executive Chairman.","Rob Levy named President, Worldwide Markets, succeeding Gratziani."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170503,"accession_number":"0001213900-25-012882","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-02-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife enters new CEO agreement with Michael Johnson through Dec 2025; base $1.28M, bonus $1.92M, $8M equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Base salary $1.28M; annual bonus target $1.92M (max 300% of salary).","Equity award $8M grant date fair value; vests 50% year 1, balance by Jan 2027 or new CEO start.","Term through Dec 31, 2025; acceleration on termination w/out cause or change in control.","Personal use of private aircraft up to $500K incremental cost per year.","Not eligible for Executive Officer Severance Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170502,"accession_number":"0001213900-25-008428","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Herbalife to redeem $65M of 7.875% Senior Notes due 2025 on Feb 11","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$65.0M aggregate principal of 7.875% Senior Notes due 2025 to be redeemed at par plus accrued interest.","Redemption date set for February 11, 2025.","Issuers: Herbalife Ltd. and wholly owned subsidiary HLF Financing, Inc.","Partial early redemption reduces outstanding debt ahead of scheduled maturity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187491,"accession_number":"0001213900-24-092256","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q3 net sales $1.2B (-3.2% YoY), adjusted EBITDA $166.5M beats guidance; FY EBITDA guidance raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.2B, down 3.2% YoY (flat constant currency); net income $47.4M, diluted EPS $0.46.","Adjusted net income $58.0M, adjusted diluted EPS $0.57; adjusted EBITDA $166.5M, margin up 70bps YoY.","Pre-tax gain on sale of property ~$4M; net cash from ops $99.5M; leverage ratio reduced to 3.3x.","Full-year 2024 guidance: net sales range narrowed, adjusted EBITDA raised, capex top end reduced.","Credit Agreement EBITDA $197.2M; total leverage ratio 3.3x at quarter end."],"consensus_eps_estimate":null,"consensus_eps_actual":0.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":3785700000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187490,"accession_number":"0001213900-24-092235","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K/A","filed_at":"2024-10-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife appoints director Perkins Miller to Compensation Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Perkins Miller appointed to Compensation Committee effective October 24, 2024.","This amends the June 2024 8-K that announced his director appointment.","No other changes to Mr. Miller's role as a director of the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203997,"accession_number":"0001193125-24-189942","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q2 adj. EBITDA $180M, beats guidance; FY 2024 EBITDA raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.3B, down 2.5% YoY but constant currency up 0.2%, driven by Latin America, EMEA, Asia Pacific.","Adjusted EBITDA $180M (highest in 7 quarters), margin up 120 bps YoY; exceeds guidance.","Diluted EPS $0.05; adjusted EPS $0.54; restructuring ($0.33) and debt extinguishment ($0.07) headwinds.","Total leverage ratio reduced to 3.5x; completed sale-leaseback of Torrance, CA office in July.","Full-year 2024 guidance: net sales forecast lowered, adjusted EBITDA raised; capex reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":0.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":2545400000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220678,"accession_number":"0001193125-24-169026","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-06-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife appoints Perkins Miller to board as new director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Perkins Miller appointed to fill newly created board seat effective June 25, 2024.","Compensation consistent with non-employee director plan as described in March 2024 proxy.","Miller will enter standard indemnification agreement; no committee assignments yet.","No arrangement or understanding for appointment; no material transactions with Miller."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220677,"accession_number":"0001193125-24-127561","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","5.07","7.01","9.01"],"status":"ready","headline":"Herbalife Q1 net sales $1.3B (+1% YoY); raises full-year adjusted EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $1.3B (+1% YoY, +2.4% cc); net income $24.3M; adjusted diluted EPS $0.49; adjusted EBITDA $138.3M above guidance.","Restructuring plan: at least $80M annual savings by 2025, $40M in 2024; $17M pre-tax charge recognized in SG&A.","Completed $1.6B senior secured refinancing on April 12.","Full-year 2024 guidance: raised adjusted EBITDA, reduced capex, reaffirmed net sales; Q2 guidance provided.","Shareholders approved amendment to 2023 Stock Incentive Plan, increasing shares available (35.4M for, 31.3M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":1264300000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220676,"accession_number":"0001193125-24-100782","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-04-18T23:59:59+00:00","items":["1.01","2.03","2.04","8.01","9.01"],"status":"ready","headline":"Herbalife closes $1.6B senior secured refinancing; issues $800M 12.25% notes due 2029","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $800M aggregate principal of 12.250% Senior Secured Notes due 2029 at 97.298% of par.","Entered into $400M Term Loan B at SOFR+6.75% (93% of face) and $400M revolver due 2028.","Proceeds to repay 2018 credit facilities and redeem $300M of 7.875% 2025 notes at 101.969%.","CFO targets Total Leverage Ratio of 3.0x by end of 2025; covenant max starts at 4.50x.","Term Loan B requires 5% quarterly amortization; notes non-callable for two years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220675,"accession_number":"0001193125-24-088825","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-04-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Herbalife prices upsized $800M senior secured notes at 12.25% due 2029","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offering upsized from $700M to $800M aggregate principal amount; priced at 97.298% of par.","Fixed annual interest rate of 12.25%, paid semi-annually on April 15 and October 15.","Net proceeds to repay borrowings under senior secured credit facility and a portion of 7.875% Senior Notes due 2025.","Expected close on April 12, 2024, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220674,"accession_number":"0001193125-24-082701","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Herbalife announces $700M senior secured notes offering due 2029 to refinance debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HLF Financing SaRL, LLC and Herbalife International, Inc. to offer $700M senior secured notes due 2029.","Proceeds to repay borrowings under existing credit facility and part of 7.875% Senior Notes due 2025.","Notes offered in private placement under Rule 144A and Regulation S; not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220673,"accession_number":"0001193125-24-082581","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife appoints Troy Hicks as COO, Frank Lamberti shifts to CCO effective May 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Troy Hicks appointed Chief Operating Officer, effective May 31, 2024, succeeding Frank Lamberti.","Frank Lamberti transitions to the newly created role of Chief Commercial Officer, effective same date.","Hicks previously served as EVP, Worldwide Operations since April 2023; joined Herbalife in 2013.","No financial or operational impact disclosed; the moves are lateral within the executive team."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240293,"accession_number":"0001193125-24-080572","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K/A","filed_at":"2024-03-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife appoints John DeSimone CFO; grants $7.25M in stock appreciation rights","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John DeSimone appointed CFO effective March 17, 2024; employment agreement executed March 27, 2024, term through March 26, 2026.","Award of SARs with grant date fair value of $7,250,000; vests 50% on first anniversary and 50% on second anniversary.","SARs have ten-year term; forfeiture on voluntary resignation or cause termination before second anniversary.","Pro-rata vesting on termination without cause; full acceleration within 24 months after change in control."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240298,"accession_number":"0001193125-24-072046","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-03-20T23:59:59+00:00","items":["2.05","5.02","7.01","9.01"],"status":"ready","headline":"Herbalife appoints John DeSimone as CFO; announces restructuring and 2024 guidance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John DeSimone appointed CFO effective March 17, 2024; Alex Amezquita remains with company.","Board approved restructuring plan requiring at least $60M pre-tax expenses in 2024, primarily severance.","Q1 2024 guidance: net sales +1-3% y-o-y; adjusted EBITDA $115-130M.","FY 2024 guidance: net sales +0-5% y-o-y; adjusted EBITDA $540-580M; capex $125-175M.","Expects at least $80M annual run-rate savings from restructuring beginning in 2025; targets gross leverage ratio 3.0x by end 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240297,"accession_number":"0001193125-24-061556","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-03-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife board member Kevin M. Jones resigns; Michael J. Levitt appointed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin M. Jones resigned from the board on March 1, 2024, under the director resignation policy.","Resignation is not due to any disagreement with the company on operations, policies, or practices.","Michael J. Levitt appointed to fill the vacancy effective March 1, 2024.","Levitt will receive standard non-employee director compensation and enter into indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240296,"accession_number":"0001157523-24-000245","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Herbalife Q4 net sales up 2.9% YoY to $1.2B; full-year net sales down 2.7% to $5.1B; initiates refinancing of 2018 loans","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $1.2B, up 2.9% YoY (2.5% constant currency); net income $10.2M, diluted EPS $0.10.","Full-year 2023 net sales $5.1B, down 2.7% vs 2022; net income $142.2M, diluted EPS $1.42, adjusted EPS $2.21.","Adjusted EBITDA Q4 $108.8M, full-year $570.6M; free cash flow $222.5M, operating cash flow $357.5M.","Transformation Program cost savings of ~$70M realized in 2023; pre-tax expenses ~$12M in Q4.","Refinancing initiated for 2018 Term Loan A and Revolving Credit Facility (due March 2025); Annual Meeting April 25, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":1.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":5062400000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240295,"accession_number":"0001193125-24-005296","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-01-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Herbalife CEO Johnson signs new deal: $1.28M salary, $8M equity, term to Dec 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary $1,280,000; annual bonus target $1,920,000 (max 300% of target).","Equity award $8,000,000 grant-date fair value: 50% RSUs, 50% SARs; vests 50% on 1-yr anniversary, 50% by Jan 3, 2026 or when new non-interim CEO appointed.","Personal use of company aircraft up to $500,000 per year.","If terminated without cause, RSUs fully vest, SARs pro-rata; forfeited if CEO resigns before Dec 31, 2024 without successor. Not eligible for Executive Officer Severance Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240294,"accession_number":"0001193125-24-000719","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2024-01-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Herbalife appoints Stephan Gratziani as President effective Jan 2, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephan Gratziani, previously Chief Strategy Officer, appointed President effective January 2, 2024.","Annual salary $650,000; target cash incentive 85% of base; eligible for long-term incentive plan.","Gratziani had served as Chief Strategy Officer since August 2023 and was a director from April to August 2023.","He was an independent distributor for over 32 years, earning $4.2M as a distributor in 2023.","He will discontinue role as Chief Strategy Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257802,"accession_number":"0001157523-23-001598","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q3 net sales $1.3B (-1.1% YoY); adj. EPS $0.65; transformation savings target raised to $60M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $1.3B, down 1.1% YoY (down 1.5% constant currency); third consecutive quarter of improved YoY trends.","Reported net income $42.8M ($0.43 diluted EPS); adjusted diluted EPS $0.65; adjusted EBITDA $163.3M (12.7% margin).","Transformation Program: now expects at least $60M cost savings in 2023 (up from $45M); $67M of total program expenses incurred to date.","Repurchased $65.5M of 2024 Convertible Notes in Q3; remaining $197.0M principal outstanding.","Launched all-new Herbalife.com website in Singapore; on track to roll out to ~40 markets by year-end."],"consensus_eps_estimate":null,"consensus_eps_actual":1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":3847400000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275150,"accession_number":"0001157523-23-001416","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Herbalife appoints top distributor Rodica Macadrai to Board following Gratziani's resignation","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rodica Macadrai appointed to Board effective Sept 10, 2023, filling seat vacated by Stephan Gratziani who resigned Aug 1 to become Chief Strategy Officer.","Macadrai is an independent distributor, earning ~$1.82M as a top earner since Jan 2022; no preferential treatment under Marketing Plan.","She will receive standard non-employee director compensation and enter the company's indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":275149,"accession_number":"0001157523-23-001228","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2023-08-02T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q2 net sales $1.3B (-5.7% YoY); EPS $0.60; board member becomes CSO; targets Q4 growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $1.3B, down 5.7% YoY (4.2% constant currency); net income $59.9M.","Diluted EPS $0.60; adjusted diluted EPS $0.74; adjusted EBITDA $169.6M.","Transformation Program: at least $90M annual cost savings expected; $45M anticipated in 2023.","Stephan Gratziani resigned from Board to become Chief Strategy Officer effective August 1, 2023.","Management states on track to return to growth in fourth quarter 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":2566100000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292562,"accession_number":"0001157523-23-000682","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["1.01","2.02","5.02","5.07","7.01","9.01"],"status":"ready","headline":"Herbalife Q1 sales down 6.3% to $1.3B, EPS $0.29; COO Schissel retiring July 1","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.3B, down 6.3% YoY (down 2.6% constant currency); reported net income $29.3M.","Reported diluted EPS $0.29; adjusted diluted EPS $0.54; Adj EBITDA $128.9M.","Transformation program one-time pre-tax expenses ~$27M in Q1; expects ~$35M savings in 2023, >$70M run rate by 2024.","COO Mark Schissel to retire July 1, 2023; succeeded by Frank Lamberti, Regional President of Americas.","Credit agreement amended to increase leverage covenant to 4.5x through Q4 2023, then step-down to 4.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":0.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":1252100000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":313234,"accession_number":"0001157523-23-000278","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2023-02-14T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Herbalife Q4 net sales down 10.4%; Full year adj. EPS $3.40 vs $4.79; no FY2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2022 net sales $5.2B, down 10.3% YoY; reported diluted EPS $3.23, adjusted $3.40 (down from $4.79).","Q4 2022 net sales $1.2B, down 10.4% YoY; reported diluted EPS $0.55, adjusted $0.53 (down from $0.57).","Reduced nominal debt by ~$60M in Q4; expects 2023 free cash flow largely to reduce debt toward 3.0x leverage target.","Withdrawing FY2023 guidance due to macroeconomic uncertainty; Transformation Program targets at least $70M annual savings.","Sales leader retention rate 67.6%; new distributors and preferred customers down ~1% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":3.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":5204400000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331755,"accession_number":"0001193125-22-312125","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-12-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Herbalife appoints Michael O. Johnson as permanent CEO with $1 salary, $10M equity grant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Johnson's term runs through Dec 31, 2023; annual base salary of $1; eligible for annual bonus of up to $2.4M payable in common shares.","Received equity awards with grant date fair value of $10M: 346,020 RSUs (vesting 2 years) and 783,699 SARs (base price $14.45, 10-year term).","Signing bonus of $250,000; not eligible for executive officer severance plan.","Half of RSUs vest on 1st anniversary, remainder on 2nd; SARs vest on 2nd anniversary with accelerated vesting upon certain termination scenarios.","Johnson previously served as CEO from 2003-2017 and 2019-2020; company cites his leadership in quadrupling sales and expanding to 95 markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331754,"accession_number":"0001193125-22-301866","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-12-09T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Herbalife issues $250M 4.25% convertible senior notes due 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $250M principal of 4.25% Convertible Senior Notes due June 15, 2028; net proceeds ~$243.5M.","Initial conversion rate: 58.8998 shares per $1,000 principal (~$16.98 per share).","Initial purchasers have option to buy an additional $37.5M principal within 13 days.","Notes are redeemable at company's option on or after June 15, 2026 if stock price exceeds 130% of conversion price.","Interest payable semiannually on June 15 and December 15, starting June 15, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331753,"accession_number":"0001193125-22-299732","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Herbalife Nutrition prices $250M 4.25% convertible notes due 2028; to repurchase $287.5M existing notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $250 million aggregate principal of 4.25% convertible senior notes due June 15, 2028, plus $37.5M option for initial purchasers.","Initial conversion price ~$16.98 per share, a 30% premium over Dec. 6 closing of $13.06.","Net proceeds estimated at $241.9M (or ~$278.4M if option fully exercised).","Proceeds plus revolving credit borrowings to repurchase $287.5M of existing 2.625% convertible notes due 2024.","Closing expected on or about Dec. 9, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331752,"accession_number":"0001193125-22-298436","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-12-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Herbalife announces $250M convertible senior notes offering due 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offering of $250M aggregate principal amount of convertible senior notes due 2028, plus option for initial purchasers to buy up to $37.5M additional.","Proceeds used to repurchase a portion of existing 2.625% convertible notes due 2024 and for general corporate purposes.","Notes will be senior unsecured obligations, settle in cash and common shares upon conversion, pay semiannual interest.","Maturity date June 15, 2028; redeemable at Company's option on or after June 15, 2026 under certain conditions.","Offering is private under Rule 144A; notes and conversion shares not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331751,"accession_number":"0001157523-22-001444","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-10-31T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q3 net sales down 9.5% to $1.3B; withdraws FY2022 guidance; CEO replaced by Michael O. Johnson as interim","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q3 2022 net sales of $1.3B, down 9.5% YoY (3.5% constant currency); reported diluted EPS $0.83, adjusted $0.91.","Withdrew full-year 2022 guidance citing macroeconomic volatility and marketplace uncertainty.","Dr. John Agwunobi stepped down as Chairman/CEO on Oct 27; Michael O. Johnson named Chairman and interim CEO.","Paid down $50M on revolving credit facility during Q3, reducing debt levels.","EVP Alan Hoffman resigning effective Nov 4, 2022 to pursue another opportunity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":349243,"accession_number":"0001157523-22-000997","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-08-02T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q2 beats guidance; President transitions to non-exec role; $400M digital plan","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $1.4B (-10.3% YoY, -5.9% FX-adjusted); adj. EPS $0.96 beat guidance; reported EPS $0.88.","President John DeSimone transitions to Executive Vice Chairman (part-time, non-exec) effective July 29, 2022.","Company announces $400M digital tech program; expects $200-250M incremental spend over 3 years.","Repurchased ~1.1M shares for $30.2M in Q2; reaffirms net sales/EBITDA guidance.","Lowers full-year adjusted EPS guidance, citing unfavorable currency movements."],"consensus_eps_estimate":null,"consensus_eps_actual":1.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":2728500000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":366133,"accession_number":"0001157523-22-000545","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-05-03T23:59:59+00:00","items":["2.02","5.07","9.01"],"status":"ready","headline":"Herbalife Q1 net sales $1.3B (-11% YoY); cuts FY2022 guidance; EPS $0.96 reported, $0.99 adjusted","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.3B, down 11% YoY; two-year stack growth 5.8% vs Q1 2020.","Reported diluted EPS $0.96; adjusted diluted EPS $0.99; reported net income $98.2M.","Adjusted EBITDA $185.6M; repurchased 2.6M shares for $101.7M during Q1.","Full-year 2022 guidance: net sales down 10% to 4%; adj. EPS $3.50-$4.00; adj. EBITDA $680-740M.","Announced margin improvement initiatives: incremental pricing actions and cost control against inflation."],"consensus_eps_estimate":null,"consensus_eps_actual":0.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":1335800000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":385622,"accession_number":"0001157523-22-000242","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2022-02-23T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Herbalife reports record FY2021 net sales of $5.8B, Q4 down 6.6%; FY2022 guidance below 2021 adjusted EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2021 net sales $5.8B (+4.7% YoY); reported diluted EPS $4.13, adjusted $4.79 (records).","Q4 net sales $1.3B (-6.6% YoY); reported EPS $0.37, adjusted $0.57 vs $0.59 and $0.71 a year ago.","FY2021 net income $447.2M, adjusted EBITDA $873.5M (records).","FY2022 guidance: net sales 0-6% growth, adjusted EPS $4.25-$4.75, adjusted EBITDA $785M-$845M.","Repurchased 20.4M shares for $983M in FY2021; plans $50M/quarter repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":4.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":5802800000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":403505,"accession_number":"0001157523-21-001306","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2021-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Herbalife Q3 net sales down 6% to $1.4B; adjusted EPS and EBITDA beat high-end guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $1.4B, down 6% YoY; reported diluted EPS $1.09, adjusted diluted EPS $1.21, both up ~5% YoY.","Adjusted EBITDA of $222.4M; adjusted EPS and EBITDA exceeded high end of guidance ranges.","Reiterated FY2021 outlook: net sales growth 4.5%–8.5%, adjusted EPS $4.55–$4.95, adjusted EBITDA $860M–$910M.","Repurchased 3.5M shares for $162M in Q3; sales leaders active up 10% YoY ex-China.","Asia Pacific net sales +11% (India +46%, 5th straight record); N.America two-year stack +38% vs Q3 2019."],"consensus_eps_estimate":null,"consensus_eps_actual":3.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":4484800000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":422465,"accession_number":"0001157523-21-001140","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2021-09-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Herbalife Nutrition cuts Q3/FY2021 guidance; net sales growth midpoint lowered 400 bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales expected down 3.5%-6.5% vs 2020; prior midpoint lowered 700 bps.","FY 2021 net sales growth revised to 4.5%-8.5% vs 2020 (midpoint down 400 bps).","Adjusted diluted EPS guidance: Q3 $1.00-$1.20; FY $4.55-$4.95 (midpoint -$0.15).","Adjusted EBITDA guidance: Q3 $200-$220M; FY $860-$910M (prior $875-$935M).","Company plans >$200M share repurchase in H2; active sales leaders up 10% vs 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":422464,"accession_number":"0001157523-21-000983","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2021-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Herbalife Q2 net sales $1.6B (+15% YoY); record adj. EBITDA $262M; raised EPS midpoint","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $1.6B (+15% YoY); reported EPS $1.31 vs $0.82; adjusted EPS $1.52 vs $0.97.","Five of six regions grew; Asia Pacific +38% (India +93%); Energy/Sports/Fitness category +45%.","Record quarterly adj. EBITDA $262.1M; first-half adj. EBITDA exceeded $500M.","FY2021 EPS guidance raised: adj. diluted $4.70-$5.10 (midpoint +$0.05); sales growth trimmed to 8.5%-12.5%.","Net income $144M (+25% YoY); ~2/3 of new distributors/preferred customers were millennials/Gen-Z."],"consensus_eps_estimate":null,"consensus_eps_actual":2.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":3053900000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":422463,"accession_number":"0001193125-21-231587","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2021-07-30T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Herbalife Nutrition amends credit agreement, increases facilities and adds sustainability pricing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Increased Term Loan A facility from ~$245M to ~$286.2M and Revolving Credit facility from $282.5M to $330M.","Reduced interest rate margins to eurocurrency rate plus 1.75%-2.25% or base rate plus 0.75%-1.25% based on leverage.","Added sustainability-linked pricing adjustment tied to S&P Global ESG score, virgin plastic, emissions, and female executives.","Intends to use additional borrowings to prepay a portion of Term Loan B facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1301051100.707893,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}